Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL723672 | 0.74 | TET2 (0.32) | TET2 | |
| SCHEMBL1227973 | 0.72 | TET2 (0.31) | TET2 | |
| SCHEMBL9715070 | 0.70 | TET2 (0.30) | TET2 | |
| Itaconate SCHEMBL4307310 | 0.65 | ALOX15 (0.54) | TET2 | |
| SCHEMBL3137653 | 0.65 | TET2 (0.31) | TET2 | |
| SCHEMBL3108322 | 0.64 | — | — | |
| SCHEMBL2689625 | 0.63 | TET2 (0.33) | TET2 | |
| SCHEMBL703731 | 0.63 | TET2 (0.33) | TET2 | |
| SCHEMBL561208 | 0.63 | — | — | |
| SCHEMBL6709319 | 0.62 | TET2 (0.36) | TET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120288797-A1 | PHOTORESIST COMPOSITIONS AND METHODS OF USE IN HIGH INDEX IMMERSION LITHOGRAPHY | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2012-11-15 | — | — | US | claimed |
| US-8236482-B2 | Photoresist compositions and methods of use in high index immersion lithography | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2012-08-07 | — | — | US | claimed |
| US-8133512-B2 | Drug delivery systems based on catonic siloxanyl macromonomers | BAUSCH & LOMB INCORPORATED (US) | 2012-03-13 | — | — | US | claimed |
| US-8133511-B2 | Drug delivery system based on cationic siloxanyl macromonomers | BAUSCH & LOMB INCORPORATED (US) | 2012-03-13 | — | — | US | claimed |
| US-20090274745-A1 | Drug delivery systems based on catonic siloxanyl macromonomers | BAUSCH & LOMB INCORPORATED (US) | 2009-11-05 | — | — | US | claimed |
| US-20090274744-A1 | Drug delivery system based on cationic siloxanyl macromonomers | BAUSCH & LOMB INCORPORATED (US) | 2009-11-05 | — | — | US | claimed |
| US-7579021-B2 | Drug delivery systems based on degradable cationic siloxanyl macromonomers | BAUSCH & LOMB INCORPORATED (US) | 2009-08-25 | — | — | US | claimed |
| US-20090181322-A1 | Photoresist Compositions and Methods of Use in High Index Immersion Lithography | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2009-07-16 | — | — | US | claimed |
| US-7544371-B2 | Drug delivery systems | BAUSCH + LOMB INCORPORATED (US) | 2009-06-09 | — | — | US | claimed |
| US-20080075780-A1 | Drug delivery systems based on degradible cationic siloxanyl macromonomers | SANTARUS, INC. | 2008-03-27 | — | — | US | claimed |
| US-20070141115-A1 | Drug delivery systems | SANTARUS, INC. | 2007-06-21 | — | — | US | claimed |
| US-9250529-B2 | Photoresist compositions and methods of use in high index immersion lithography | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2016-02-02 | — | — | US | disclosed |
| US-20120288797-A1 | PHOTORESIST COMPOSITIONS AND METHODS OF USE IN HIGH INDEX IMMERSION LITHOGRAPHY | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2012-11-15 | — | — | US | disclosed |
| US-8236482-B2 | Photoresist compositions and methods of use in high index immersion lithography | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2012-08-07 | — | — | US | disclosed |
| US-8133511-B2 | Drug delivery system based on cationic siloxanyl macromonomers | BAUSCH & LOMB INCORPORATED (US) | 2012-03-13 | — | — | US | disclosed |
| US-20090181321-A1 | Photoresist Compositions and Methods of Use in High Index Immersion Lithography | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2009-07-16 | — | — | US | disclosed |
| US-20090181322-A1 | Photoresist Compositions and Methods of Use in High Index Immersion Lithography | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2009-07-16 | — | — | US | disclosed |
| US-7544371-B2 | Drug delivery systems | BAUSCH + LOMB INCORPORATED (US) | 2009-06-09 | — | — | US | disclosed |
| US-20080075780-A1 | Drug delivery systems based on degradible cationic siloxanyl macromonomers | SANTARUS, INC. | 2008-03-27 | — | — | US | disclosed |
| US-20070141115-A1 | Drug delivery systems | SANTARUS, INC. | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274744-A1 | Drug delivery system based on cationic siloxanyl macromonomers | MSR1, LPXN, SRRM2 | TET2 2354/4885 |
| US-20090274745-A1 | Drug delivery systems based on catonic siloxanyl macromonomers | MMP13, LPXN, SLC13A2 | TET2 1216/4885 |
| US-20070141115-A1 | Drug delivery systems | ZYX, SRRM2, MTX1 | TET2 3414/4885 |
| US-20080075780-A1 | Drug delivery systems based on degradible cationic siloxanyl macromonomers | MSR1, LPXN, SRRM2 | TET2 1311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.